Workshop on the draft guideline on registry-based studies

This half-day virtual workshop will give an overview of the draft guideline on registry-based studies. Stakeholders will have the opportunity to discuss questions, perspectives on the usefulness of the document and recent experience on methodological aspects of registry-based studies, such as the use of a large registry for clinical trials.

EMA’s cross-committee task force has developed the draft guideline. It is open for public consultation until 31 December 2020. For more information, see the EMA Patient registries web page.